Get the Stockscreener App
51.50
9.60%
4.51
After Hours:
49.30
-2.20
-4.27%
Anbio Biotechnology stock is traded at $51.50, with a volume of 142.82K.
It is up +9.60% in the last 24 hours and up +219.88% over the past month.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
See More
Previous Close:
$46.99
Open:
$47.51
24h Volume:
142.82K
Relative Volume:
1.39
Market Cap:
$2.26B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+8.06%
1M Performance:
+219.88%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$47.51
$51.63
1-Week Range:
$41.72
$55.65
52-Week Range:
$5.60
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
Name
Anbio Biotechnology
Sector
Industry
Phone
-
Address
-
Compare NNNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
51.50 | 2.09B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
516.12 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
175.33 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.16 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
261.07 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
210.08 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
Anbio Biotechnology Stock (NNNN) Latest News
Is Anbio Biotechnology a good long term investmentConsistently high returns - Autocar Professional
Anbio Biotechnology Stock Analysis and ForecastRecord-breaking gains - Autocar Professional
What analysts say about Anbio Biotechnology stockUnmatched profit growth - jammulinksnews.com
What drives Anbio Biotechnology stock priceTriple-digit profit margins - jammulinksnews.com
Can Vaxart Inc. stock recover from recent decline3x Growth Potential - Newser
What institutions are buying Vertiv Holdings Co stock now200 Percent Watchlist - Newser
Anbio Biotechnology Plunges 7.9% Amid Sector-Wide Turmoil: What's Driving the Bloodletting? - AInvest
Generation Bio (GBIO) Rockets 26.7% Amid Technical Breakout—What’s Next? - AInvest
Why Anbio Biotechnology stock attracts strong analyst attentionFree Stock Market Return Analysis - beatles.ru
Why INMB stock attracts strong analyst attentionExplosive Growth Potential - Newser
What makes Anbio Biotechnology stock price move sharplyFree Stock Selection with 300% Return - Newser
How Anbio Biotechnology stock performs during market volatilityFree Access to Community - Newser
Anbio Biotechnology Soars to 52-Week High – Can This Breakout Withstand Overbought Pressure? - AInvest
Anbio Biotechnology (NNNN) up more than 500% since Jun 16 - AInvest
How Focus Universal Inc. stock performs during market volatilityFree Elite Traders Group - Newser
CULT(milady cult coin) Tokenomics ExplainedMarket Ready Callouts - Newser
The trading volume of NNNN has been increasing recently. Will its stock price rise? - AInvest
Anbio Biotechnology Plummets 9%—Is the Slide Just Getting Started? - AInvest
Anbio Biotechnology Plummets 10%—Is This a Technical Correction or a Warning? - AInvest
Anbio Biotechnology (NASDAQ:NNNN) Has A ROE Of 14% - Yahoo Finance
Here Is What You Need To Know Before Investing In Anbio Biotechnology (NNNN) - Yahoo Finance
Anbio Biotechnology (NNNN) Soars 16.29% to Record High on Investor Enthusiasm - AInvest
Anbio Biotechnology Enhances NASDAQ Composite Diagnostics Capacity After Pandemic - Kalkine Media
Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday - inkl
Stocks To Watch: BeOne Medicines ADR Sees RS Rating Rise To 83 - inkl
The 2025 IPO Resurgence: AI, Crypto, and ESG Lead the Charge - AInvest
Catalyst Watch: Jobs Report, Tesla deliveries, Constellation Brands earnings, and Circle ratings - MSN
H.B. Fuller Posts Better-Than-Expected Earnings, Joins AeroVironment, MillerKnoll And Other Big Stocks Moving Higher On ThursdayAlcoa (NYSE:AA), AeroVironment (NASDAQ:AVAV) - Benzinga
U.S. Stock Movers Today: ULY, NNNN, QS, GCTK, RITR - Markets.com
Annovis Bio Plunges 10.13% on Analyst Price Target Cut - AInvest
Pre-market Movers: INDP, IBO, CDTX, FBRX... - RTTNews
Is the frenzy of IPOs on Wall Street returning? Circle and Airo doubled on their first day of listing, while CoreWeave has skyrocketed 300% in four months. - 富途牛牛
Anbio Biotechnology: Risky Valuation Concerns As COVID-Related Sales Decline (NNNN) - Seeking Alpha
Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions - FinancialContent
Anbio Biotechnology to Showcase Innovative Diagnostic Solutions at Key International Exhibitions in May 2025 - Nasdaq
Anbio Expands Global Diagnostics Reach: 90+ Tests, 100+ Countries, and 3 Major Exhibition Debuts - Stock Titan
Anbio Biotechnology Stock (NNNN) Financials Data
There is no financial data for Anbio Biotechnology (NNNN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):